Angiogenesis inhibitors and radiotherapy of primary tumours.
Expert Opin Biol Ther.
2002 Jun;2(5):477-81. doi: 10.1517/14712598.2.5.477. Review. PubMed PMID:
12079484.
Radiation abscopal antitumor effect is mediated through p53.
Cancer Res.
2003 Apr 15;63(8):1990-3. PubMed PMID:
12702593.
Evaluation of copper chelation agents as anti-angiogenic therapy.
Bioorg Med Chem.
2003 Sep 15;11(19):4287-93. doi: 10.1016/s0968-0896(03)00401-2. PubMed PMID:
12951159.
Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results.
Semin Oncol.
2003 Dec;30(6 Suppl 18):63-7. doi: 10.1053/j.seminoncol.2003.11.016. PubMed PMID:
14727242.
Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood.
Environ Mol Mutagen.
2004;44(5):427-35. doi: 10.1002/em.20075. PubMed PMID:
15517570.
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
J Clin Oncol.
2004 Feb 1;22(3):499-506. doi: 10.1200/JCO.2004.07.022. PubMed PMID:
14752073.
In vivo tumor imaging using a near-infrared-labeled endostatin molecule.
Int J Radiat Oncol Biol Phys.
2004 Feb 1;58(2):536-41. doi: 10.1016/j.ijrobp.2003.09.068. PubMed PMID:
14751525.
Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated.
Int J Radiat Oncol Biol Phys.
2004 Apr 1;58(5):1536-9. doi: 10.1016/j.ijrobp.2003.09.011. PubMed PMID:
15050334.
In vivo tumor imaging in mice with near-infrared labeled endostatin.
Mol Cancer Ther.
2004 Apr;3(4):481-8. PubMed PMID:
15078992.
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors.
BMC Cancer.
2004 May 19;4:20. doi: 10.1186/1471-2407-4-20. PubMed PMID:
15151703; PubMed Central PMCID:
PMC441381.
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.
Int J Radiat Oncol Biol Phys.
2004 Aug 1;59(5):1414-23. doi: 10.1016/j.ijrobp.2004.01.016. PubMed PMID:
15275727; PubMed Central PMCID:
PMC2396328.
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.
Magn Reson Med.
2004 Sep;52(3):683-7. doi: 10.1002/mrm.20138. PubMed PMID:
15334592; PubMed Central PMCID:
PMC2396258.
An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement.
Mol Imaging.
2005 Jan-Mar;4(1):63-6. doi: 10.1162/15353500200504181. PubMed PMID:
15967127; PubMed Central PMCID:
PMC3299492.
Design of a novel MRI compatible manipulator for image guided prostate interventions.
IEEE Trans Biomed Eng.
2005 Feb;52(2):306-13. doi: 10.1109/TBME.2004.840497. PubMed PMID:
15709668; PubMed Central PMCID:
PMC3299496.
Inverse treatment planning based on MRI for HDR prostate brachytherapy.
Int J Radiat Oncol Biol Phys.
2005 Mar 15;61(4):1267-75. doi: 10.1016/j.ijrobp.2004.11.024. PubMed PMID:
15752909.
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.
Clin Cancer Res.
2005 May 1;11(9):3353-62. doi: 10.1158/1078-0432.CCR-04-2062. PubMed PMID:
15867235.
MR-guided interventions for prostate cancer.
Magn Reson Imaging Clin N Am.
2005 Aug;13(3):491-504. doi: 10.1016/j.mric.2005.04.012. Review. PubMed PMID:
16084415.
Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
Int J Radiat Oncol Biol Phys.
2005 Aug 1;62(5):1316-21. doi: 10.1016/j.ijrobp.2004.12.083. PubMed PMID:
16029787.
Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Int J Radiat Oncol Biol Phys.
2006 Jan 1;64(1):15-25. doi: 10.1016/j.ijrobp.2005.03.065. PubMed PMID:
16377411.
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.
J Urol.
2006 Jan;175(1):113-20. doi: 10.1016/S0022-5347(05)00065-0. PubMed PMID:
16406885; PubMed Central PMCID:
PMC3299542.
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Cancer Res.
2006 Feb 1;66(3):1844-50. doi: 10.1158/0008-5472.CAN-05-3466. PubMed PMID:
16452246.
Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers.
Radiat Oncol.
2006 Feb 28;1:2. doi: 10.1186/1748-717X-1-2. PubMed PMID:
16722575; PubMed Central PMCID:
PMC1436003.
Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.
Int J Radiat Oncol Biol Phys.
2006 Jul 15;65(4):1008-13. doi: 10.1016/j.ijrobp.2006.02.030. Epub 2006 May 26. PubMed PMID:
16730138.
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost.
Radiat Oncol.
2006 Aug 16;1:28. doi: 10.1186/1748-717X-1-28. PubMed PMID:
16914054; PubMed Central PMCID:
PMC1564026.
Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital.
Cancer.
2007 Mar 15;109(6):1203-10. doi: 10.1002/cncr.22499. PubMed PMID:
17318817.
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.
Cancer Res.
2007 Jul 1;67(13):6022-5. doi: 10.1158/0008-5472.CAN-07-0561. PubMed PMID:
17616657.
Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning.
Int J Radiat Oncol Biol Phys.
2007 Aug 1;68(5):1522-8. doi: 10.1016/j.ijrobp.2007.04.004. PubMed PMID:
17674983.
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.
Int J Radiat Oncol Biol Phys.
2007 Nov 15;69(4):1084-9. doi: 10.1016/j.ijrobp.2007.04.049. Epub 2007 Jul 2. PubMed PMID:
17606331.
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.
Int J Radiat Oncol Biol Phys.
2007 Nov 15;69(4):1090-9. doi: 10.1016/j.ijrobp.2007.04.068. PubMed PMID:
17967303.
Role of fractionated external beam radiotherapy in hemangioblastoma of the central nervous system.
Int J Radiat Oncol Biol Phys.
2007 Dec 1;69(5):1521-6. doi: 10.1016/j.ijrobp.2007.05.025. Epub 2007 Sep 14. PubMed PMID:
17869023.
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
BJU Int.
2008 Jan;101(2):181-5. doi: 10.1111/j.1464-410X.2007.07219.x. Epub 2007 Oct 8. PubMed PMID:
17922874.
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.
Int J Radiat Oncol Biol Phys.
2008 Jan 1;70(1):90-5. doi: 10.1016/j.ijrobp.2007.05.057. Epub 2007 Sep 12. PubMed PMID:
17855015; PubMed Central PMCID:
PMC2267374.
Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Int J Radiat Oncol Biol Phys.
2008 Feb 1;70(2):425-30. doi: 10.1016/j.ijrobp.2007.06.029. Epub 2007 Sep 19. PubMed PMID:
17881141.
Validation of supervised automated algorithm for fast quantitative evaluation of organ motion on magnetic resonance imaging.
Int J Radiat Oncol Biol Phys.
2008 Jul 15;71(4):1253-60. doi: 10.1016/j.ijrobp.2007.11.021. Epub 2008 Jan 22. PubMed PMID:
18207656.
Accuracy and sensitivity of finite element model-based deformable registration of the prostate.
Med Phys.
2008 Sep;35(9):4019-25. doi: 10.1118/1.2965263. PubMed PMID:
18841853.
Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials.
Cancer Metastasis Rev.
2008 Sep;27(3):375-85. doi: 10.1007/s10555-008-9139-6. Review. PubMed PMID:
18427732.
Complications of Gamma Knife surgery: an early report from 2 Canadian centers.
J Neurosurg.
2008 Dec;109 Suppl:2-7. doi: 10.3171/JNS/2008/109/12/S2. PubMed PMID:
19123881.
Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses.
Radiother Oncol.
2009 Mar;90(3):325-30. doi: 10.1016/j.radonc.2008.11.015. Epub 2008 Dec 31. PubMed PMID:
19121547.
Challenges in clinical prostate cancer: role of imaging.
AJR Am J Roentgenol.
2009 Jun;192(6):1455-70. doi: 10.2214/AJR.09.2579. PubMed PMID:
19457806; PubMed Central PMCID:
PMC2893141.
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
Int J Radiat Oncol Biol Phys.
2009 Jun 1;74(2):383-7. doi: 10.1016/j.ijrobp.2008.08.002. Epub 2008 Oct 22. PubMed PMID:
18947938; PubMed Central PMCID:
PMC2905150.
Advances in technology for intracranial stereotactic radiosurgery.
Technol Cancer Res Treat.
2009 Aug;8(4):271-80. doi: 10.1177/153303460900800404. Review. PubMed PMID:
19645520.
Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.
Clin Cancer Res.
2009 Sep 1;15(17):5576-83. doi: 10.1158/1078-0432.CCR-09-0245. Epub 2009 Aug 25. PubMed PMID:
19706801.
Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer.
Int J Radiat Biol.
2009 Sep;85(9):805-13. doi: 10.1080/09553000903043059. PubMed PMID:
19728195.
Dosimetric comparison of intensity-modulated radiosurgery and helical tomotherapy for the treatment of multiple intracranial metastases.
Technol Cancer Res Treat.
2009 Oct;8(5):361-7. doi: 10.1177/153303460900800506. PubMed PMID:
19754212.
Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapy.
J Urol.
2009 Nov;182(5):2280-4. doi: 10.1016/j.juro.2009.07.037. Epub 2009 Sep 16. PubMed PMID:
19762047.
Image guided dose escalated prostate radiotherapy: still room to improve.
Radiat Oncol.
2009 Nov 3;4:50. doi: 10.1186/1748-717X-4-50. PubMed PMID:
19887007; PubMed Central PMCID:
PMC2777178.
Imaging in radiation oncology: a perspective.
Oncologist.
2010;15(4):338-49. doi: 10.1634/theoncologist.2009-S106. Review. PubMed PMID:
20413639; PubMed Central PMCID:
PMC3227970.
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys.
2010 Feb 1;76(2):361-8. doi: 10.1016/j.ijrobp.2009.02.006. Epub 2009 Apr 23. PubMed PMID:
19394158; PubMed Central PMCID:
PMC2847420.
Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer.
Can Urol Assoc J.
2010 Apr;4(2):105-11. doi: 10.5489/cuaj.801. PubMed PMID:
20368892; PubMed Central PMCID:
PMC2845745.
Clinical evaluation of stereotactic target localization using 3-Tesla MRI for radiosurgery planning.
Int J Radiat Oncol Biol Phys.
2010 Apr;76(5):1472-9. doi: 10.1016/j.ijrobp.2009.03.020. Epub 2009 Jun 8. PubMed PMID:
19515512.
What would you like to do?